APH three-lens brief
Evidence-based stock research on APH. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 13.8pp over 30 days. · Debt-to-equity of 133.1 — balance-sheet-heavy.
- Underperforming SPY by 13.8pp over 30 days.
- Analyst mean target $181.72 — 44% above current (18 analysts).
- Debt-to-equity of 133.1 — balance-sheet-heavy.
APH closed at $125.91 (-1.54%) as of 2026-05-13. Market cap: $154.89B. P/E (trailing) 36.2. Positives: analyst mean target $181.72 — 44% above current (18 analysts).. Concerns: underperforming SPY by 13.8pp over 30 days.; debt-to-equity of 133.1 — balance-sheet-heavy.. Last quarter: Revenue $7.62B, net income $933.00M, free cash flow $3.56B.
Why three lenses on APH, not one.
A single reasoning model has blind spots it doesn’t know about. We examine APHacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/APH" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath APH brief"></iframe>